Drug profile · INN
ulipristal acetate
ELLAONE
ulipristal acetate (ELLAONE) is a progesterone receptor modulator. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — ulipristal acetate
- US status
- approved
- Class
- Genito-urinary system and sex hormones (G03)
- Route
- ORAL
- Patents
- 20
- Programs
- 20
- Data quality
- 0.89
Quick answer
ulipristal acetate (ELLAONE) is a progesterone receptor modulator. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Progesterone receptor modulator
Primary target: Progesterone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
WO 2026024938
MÉTHODES DE RÉDUCTION DE LA TRANSMISSION INTRA-UTÉRINE D'UNE INFECTION À SALMONELLA DUBLIN
granted -
US 12419942
Use of the Salmonella spp type III secretion proteins as a protective vaccination
granted -
US 12390512
Depolymerase capable of degrading extracellular polymeric substances of Klebsiella pneumoniae
granted -
US 12203143
Methods and kits to identify Klebsiella strains
granted -
US 12071636
Pasteurella multocida strains and vaccines having hyaC and nanP deletions
granted -
US 11717542
Using tumor-navigating Salmonella to modulate tumor metabolism
granted -
US 11529312
Francisella lipids as broad anti-inflammatory therapeutics and associated methods of use
granted -
US 11519007
Tumor-navigating, self-eradicating, trail-armed salmonella for precision cancer therapy
granted -
US 11464843
Use of the salmonella SPP type III secretion proteins as a protective vaccination
granted -
US 11382897
Therapeutic combination for treatment of cerebellar ataxia
granted -
US 11364304
Crosslinked micellar spherical nucleic acids
granted -
US 11352447
Gellan gum hydrogels, preparation, methods and uses thereof
granted -
US 11248270
Methods and kits to identify Klebsiella strains
granted -
US 10927193
Gellan gum-based hydrogels, methods and uses thereof
granted -
US 10815455
Salmonella-based vectors for cancer immunotherapy targeting Wilms' tumor gene WT1
granted -
US 10780154
Salmonella paratyphi A with an O-antigen having an extended carbohydrate chain and use thereof
granted -
US 10772897
Method for on-demand contraception
granted -
US 10548962
Use of the salmonella SPP type III secretion proteins as a protective vaccination
granted -
US 10351606
Mutated Salmonella enterica
granted -
US 10159681
Method for on-demand contraception
granted
Frequently asked questions
What is ulipristal acetate?
ulipristal acetate (ELLAONE) is a progesterone receptor modulator. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ulipristal acetate?
ELLAONE is a marketed brand name for ulipristal acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ulipristal acetate?
ulipristal acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.